APELS: Breathiomics in acute pulmonary embolism

• Conditions: pulmonary embolism; venous thromboembolism; 10014523

• Registration Number: NL-OMON33696
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 75

Inclusion Criteria

Patients with clinically suspected pulmonary embolism

Exclusion Criteria

Age < 18 years
LMWH or unfractionated heparin 24 hrs or more prior to eligibility assessment
vitamin K antagonists (coumarin derivates)
inability to perform the electronis nose test

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>the smell-print provided by the electronic nose. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p> the negative and positive predictive values for the diagnosis of pulmonary<br /><br>embolism. </p><br>